MY100721A - Therapeutic agent. - Google Patents

Therapeutic agent.

Info

Publication number
MY100721A
MY100721A MYPI87000032A MYPI19870032A MY100721A MY 100721 A MY100721 A MY 100721A MY PI87000032 A MYPI87000032 A MY PI87000032A MY PI19870032 A MYPI19870032 A MY PI19870032A MY 100721 A MY100721 A MY 100721A
Authority
MY
Malaysia
Prior art keywords
therapeutic agent
flurbiprofen
ibuprofen
active ingredient
sustained release
Prior art date
Application number
MYPI87000032A
Inventor
Francis Lampard John
David Melia Colin
Govind Pankhania Mahendra
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of MY100721A publication Critical patent/MY100721A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A SUSTAINED RELEASE PHARMACEUTICAL FORMULATION COMPRISING XANTHAN GUM, A PHARMACEUTICALLY ACTIVE INGREDIENT FOR EXAMPLE, IBUPROFEN OR FLURBIPROFEN, AND OTHER OPTIONAL EXCIPIENTS.
MYPI87000032A 1986-01-18 1987-01-14 Therapeutic agent. MY100721A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868601204A GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY100721A true MY100721A (en) 1991-01-31

Family

ID=10591589

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87000032A MY100721A (en) 1986-01-18 1987-01-14 Therapeutic agent.

Country Status (23)

Country Link
US (1) US5415871A (en)
EP (1) EP0234670B1 (en)
JP (1) JPH0669965B2 (en)
KR (1) KR940011242B1 (en)
AT (1) ATE77548T1 (en)
AU (2) AU608208B2 (en)
CA (1) CA1313133C (en)
DE (1) DE3779933T2 (en)
DK (1) DK175215B1 (en)
ES (1) ES2042541T4 (en)
FI (1) FI93608C (en)
GB (1) GB8601204D0 (en)
GR (1) GR3005796T3 (en)
IE (1) IE59333B1 (en)
IL (1) IL81281A (en)
IN (1) IN164250B (en)
MX (1) MX4949A (en)
MY (1) MY100721A (en)
NO (1) NO173317C (en)
NZ (1) NZ218907A (en)
PH (1) PH26408A (en)
PT (1) PT84133B (en)
ZA (1) ZA87173B (en)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191674B (en) * 1986-03-07 1988-03-23 Eurand Spa FORMULATIONS FOR THE PREPARATION OF PROLONGED-RELEASE DRUGS SUITABLE FOR ORAL ADMINISTRATION
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
IT1250483B (en) * 1990-08-30 1995-04-07 Eurand Int MULTIPLE DIE DELAY SYSTEM
DE4140183C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retard form for a medicine containing flurbiprofen
DE4140192C2 (en) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-controlled gelatin-based thermocolloid matrix for peroral sustained release forms
DE4140179C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Acute form for a drug containing ibuprofen
DE4140172C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retard form for a drug containing ibuprofen
DE4140184C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Acute form for a medicine containing flurbiprofen
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp Readily available konjac glucomannan sustained release excipient.
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5662933A (en) 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5464067A (en) * 1994-01-11 1995-11-07 Dulak; Joseph O. Golf marker cleaner and grass remover
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
FR2729857B1 (en) 1995-01-27 1997-04-04 Rhone Poulenc Chimie PHARMACEUTICAL COMPOSITIONS IN THE FORM OF SUSTAINED-RELEASE TABLETS BASED ON GRANULES OF HIGH MOLECULAR POLYSACCHARIDES
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
JP3148256B2 (en) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド Sustained release matrix for high dose poorly soluble drugs
IN186245B (en) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030153623A1 (en) * 1998-07-22 2003-08-14 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble NSAIDs
GB9816723D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
WO2000033818A1 (en) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
DE60038536T2 (en) 1999-09-30 2009-06-10 Penwest Pharmaceuticals Co. MATRIX SYSTEM WITH DELAYED RELEASE FOR HIGHLY SOLUBLE ACTIVE SUBSTANCES
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
AU2001284561A2 (en) * 2000-08-22 2002-03-04 Agresearch Limited A release composition and method of preparation
AU8456001A (en) * 2000-08-22 2002-03-04 Agres Ltd A thermo-stable bio-matrix
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002041876A1 (en) * 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
CA2452871C (en) * 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
ES2259011T3 (en) * 2001-11-19 2006-09-16 Lupin Limited PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF AN ANTIBIOTIC BETA-LACTAMA.
KR20050009983A (en) * 2002-03-22 2005-01-26 시락 아게 Sustained release formulation of tramadol
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
RU2005122008A (en) * 2002-12-13 2006-02-10 Цилаг Аг (Ch) CONTROLLED RELEASE PRODUCTS CONTAINING TRAMADOL AND TOPIRAMAT
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
EP1510205B1 (en) * 2003-09-01 2008-03-26 JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universal controlled-release composition comprising xanthan gum and sodium alginate
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
ES2244324B1 (en) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. DIURETIC COMPOSITIONS OF PROLONGED RELEASE.
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
AU2005280058B2 (en) 2004-08-25 2010-09-02 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006046954A1 (en) * 2004-10-26 2006-05-04 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
ES2403069T3 (en) * 2005-02-22 2013-05-13 Sun Pharma Advanced Research Company Ltd Oral controlled release composition containing levetiracetam
US9757384B2 (en) 2005-04-06 2017-09-12 Essentialis, Inc. Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
CA2633266C (en) * 2005-12-16 2011-08-02 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
ES2374963T3 (en) 2006-01-05 2012-02-23 Essentialis, Inc. SALES OF OPENING AGENTS OF THE ATP DEPENDENT CHANNEL OF ATP AND USES OF THE SAME.
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
CN104825397A (en) * 2006-04-03 2015-08-12 伊萨·奥迪迪 Controlled Release Delivery Devices Containing Organosol Coatings
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US20080318994A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
WO2009006483A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
DE102007032662A1 (en) * 2007-07-13 2009-01-22 Beiersdorf Ag Formulation for protecting skin aging caused by intrinsic or extrinsic factors, and for treating itching skin and atopic eczema, has apiogalacturonan or apiogalacturonan containing extract of Zostera marina and one or multiple hydrocolloids
EP2540294B1 (en) * 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
WO2013095317A2 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
EP2797583B1 (en) 2011-12-27 2015-09-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
WO2013130411A1 (en) 2012-02-27 2013-09-06 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
WO2014007778A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs
WO2014007777A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined capsule formulations of nsaids
NZ768958A (en) 2014-11-14 2021-07-30 Essentialis Inc Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
CN108904451A (en) * 2018-07-27 2018-11-30 广州柏赛罗药业有限公司 Sustained release preparation
CN114177155B (en) * 2020-09-08 2023-10-03 越洋医药开发(广州)有限公司 Ibuprofen controlled release tablet and preparation method thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901111A (en) * 1943-08-31 1945-07-18 Improvement in tilting plow depth adjustment devices
US3065143A (en) 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
FR2138492A1 (en) * 1971-05-27 1973-01-05 Cerm Cent Europ Rech Mauvernay Basic aluminium salts of gum xanthane - pharmaceutical gelling agents
DE2130545A1 (en) 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmaceutical molded body
US4163777A (en) 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
JPS5470420A (en) * 1977-11-10 1979-06-06 Sanei Kagaku Kogyo Kk Binder for medical tablet
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
IN151913B (en) * 1980-01-11 1983-09-03 Boots Co Ltd
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
JPS60219238A (en) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc Formed product containing slowly disintegrating pullulan and its production
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
DE3440288C2 (en) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmaceutical preparation containing ibuprofen and process for its preparation
EP0182772A3 (en) * 1984-11-22 1987-04-01 Benfar Sustained-release pharmaceutical compositions, process for their preparation and their use
BE901111A (en) * 1984-11-22 1985-03-15 Benfar Representee Par Vanderl Slow release oral pharmaceutical compsn. - having excipient contg. di:methyl-polysiloxane, silica, polymeric carbohydrate(s) and algae
JPS61130239A (en) * 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd Complex
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
IT1191674B (en) * 1986-03-07 1988-03-23 Eurand Spa FORMULATIONS FOR THE PREPARATION OF PROLONGED-RELEASE DRUGS SUITABLE FOR ORAL ADMINISTRATION
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient

Also Published As

Publication number Publication date
IL81281A (en) 1990-11-29
CA1313133C (en) 1993-01-26
PT84133A (en) 1987-02-01
IE863420L (en) 1987-07-18
GR3005796T3 (en) 1993-06-07
EP0234670B1 (en) 1992-06-24
FI870155A0 (en) 1987-01-15
AU608208B2 (en) 1991-03-28
JPS62181227A (en) 1987-08-08
JPH0669965B2 (en) 1994-09-07
NO173317C (en) 1993-12-01
IE59333B1 (en) 1994-02-09
ES2042541T3 (en) 1993-12-16
EP0234670A2 (en) 1987-09-02
ZA87173B (en) 1987-08-26
NO870181L (en) 1987-07-20
NO870181D0 (en) 1987-01-16
DK175215B1 (en) 2004-07-12
ES2042541T4 (en) 1996-07-16
DK14887D0 (en) 1987-01-13
KR870006896A (en) 1987-08-13
FI870155L (en) 1987-07-19
IL81281A0 (en) 1987-08-31
KR940011242B1 (en) 1994-12-03
FI93608C (en) 1995-05-10
NO173317B (en) 1993-08-23
AU6762587A (en) 1987-07-23
DE3779933D1 (en) 1992-07-30
AU7946291A (en) 1991-09-12
PT84133B (en) 1989-05-31
MX4949A (en) 1993-12-01
DE3779933T2 (en) 1992-12-10
DK14887A (en) 1987-07-19
IN164250B (en) 1989-02-04
PH26408A (en) 1992-07-02
NZ218907A (en) 1989-05-29
FI93608B (en) 1995-01-31
GB8601204D0 (en) 1986-02-19
US5415871A (en) 1995-05-16
ATE77548T1 (en) 1992-07-15
AU628754B2 (en) 1992-09-17
EP0234670A3 (en) 1988-01-13

Similar Documents

Publication Publication Date Title
MY100721A (en) Therapeutic agent.
SI0642788T1 (en) Tramadol salt containing medicaments with sustained release of the active ingredient
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
MY118371A (en) Tetrahydrolipstatin containing compositions
TW429154B (en) A controlled release formulation for poorly soluble basic drugs
NO912001L (en) BUCCAL TABLET WITH FAST DELIVERY.
IT8619675A0 (en) FORMULATIONS FOR THE PREPARATION OF PROLONGED-RELEASE DRUGS SUITABLE FOR ORAL ADMINISTRATION.
IE871584L (en) Sustained release capsule.
CA2004598A1 (en) Medicinal aerosol formulations
DK0841903T3 (en) Oral pharmaceutical preparations containing antimicrobially active active substances and sustained release pantoprazole
CO4910114A1 (en) PHARMACEUTICAL FORMULATIONS FOR SUPPLY OF SUSTAINED DRUGS
EP2103303A3 (en) Controlled release formulation containing tramadol
AU651894B2 (en) Matrix tablet permitting the sustained release of indapamide after oral administration
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
ATE66143T1 (en) SLOW RELEASE SOLID PREPARATION.
HUP0004383A2 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
MY101593A (en) Sustained release preparation.
SE9301171D0 (en) PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS
UA27058C2 (en) Ibuprofen-containing pharmaceutical composition for the preparation of effervescent powders or tablets, pharmaceutical preparation on said and method of its preparing
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
ATE234096T1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION CONTAINING THE ACTIVE INGREDIENT MORPHINE-6-GLUCURONIDE
NO950950L (en) Pharmaceutical preparation
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
ES2135424T3 (en) ORAL COMPOSITION BASED ON IBUPROFEN.
CO4910116A1 (en) CONTROLLED RELEASE FORMULATION FOR BASIC PHARMACS SLIMMY SOLUBLE